FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Buy Opinion On Shares Of Zions Bancorporation

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

After digesting Q1 earnings, we raise our 12-month target price by $2 to $82, 12.2x our 2027 EPS estimate, a premium to the peer average of 10.0x given solid balance sheet growth prospects. We increase our 2026 EPS estimate by $0.22 to $6.44 and raise 2027's by $0.19 to $6.74. Our 2026 and 2027 revenue projections are $3.5 billion and $3.7 billion, respectively. ZION has demonstrated strong market share gains in recent quarters, standing out as one of the few banks to achieve both loan and deposit growth for two consecutive quarters. While the company has been conservative with share buybacks, reducing shares outstanding by only 1% over three years, we anticipate more aggressive repurchases ahead. This shift is supported by three factors: credit concerns from 2025 have largely subsided, ZION maintains a robust capital position with a CET1 ratio of 11.5% that exceeds peer averages despite already strong credit metrics, and the regulatory environment is improving.

Related Articles

Research

Research Alert: Thermo Fisher Scientific: Q1 Results Top Estimates As Clario Acquisition Closes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:TMO delivered Q1 top- and bottom-line beats with adjusted EPS of $5.44 vs. the $5.15 consensus and revenue of $11.01B (+6% Y/Y), though organic growth remained modest at 1% as the $8.9B Clario acquisition contributed significantly to performance. Mixed segment performance showed Life Sciences Solutions strength at $2.64B (+13% Y/Y) with improved 36.2% margin benefiting from the Solventum acquisition, while Analytical Instruments faced flat revenue and significant margin compression to 20.7% from 23.2% the prior year reflecting ongoing equipment spending pressures. FCF surged to $825M from $373M, supporting return of capital to shareholders. TMO returned $3.0B through share repurchases and increased its dividend 10%. The company plans to update 2026 financial guidance during the upcoming earnings call. We believe the robust cash flow performance and disciplined capital allocation activities support TMO's operational resilience despite the challenging life sciences tools operating environment.

$TMO
Research

Research Alert: Kdp: Q1 Ahead Of Expectations; Company Split On Track

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Keurig Dr Pepper (KDP) posted Q1 adjusted EPS of $0.39 vs. $0.42 (-7%), ahead of the $0.37 consensus. Net sales rose 9.4% Y/Y to $3.98B ($150M ahead of consensus), but gross margin contracted 180 basis points to 52.8% (20 bps above consensus). On a constant currency basis, net sales were up 8.1%, attributed to price realizations (+5.5%) and volume/mix (+2.6%). The U.S. Refreshment Beverages segment was the standout performer, with net sales rising 11.9% to $2.6B, led by volume/mix (+7.2%) and favorable net price realizations (+4.7%). The U.S. Coffee segment remained a drag on overall performance, with net sales declining 2.3% to $857M as volume/mix (-8.2%) more than offset net price realizations (+5.9%). KDP maintained prior 2026 guidance. This was a solid earnings release, with top- and bottom-line results exceeding consensus. With the JDE Peet's acquisition complete and plans for separation into two pure-play companies, management is now focused on positioning both entities for long-term success.

$KDP
Australia

LSI Industries Fiscal Q3 Adjusted EPS, Sales Rise; Shares Up Pre-Bell

LSI Industries (LYTS) reported fiscal third-quarter adjusted earnings Thursday of $0.28 per diluted share, up from $0.20 a year earlier.Three analysts polled by FactSet expected $0.18.Net sales for the quarter ended March 31 were $150.5 million, up from $132.5 million a year earlier.Three analysts surveyed by FactSet expected $138.7 million.The company maintained its quarterly dividend at $0.05 a share, payable May 12 to holders of record on May 4.Shares of the company rose 6.2% in Thursday premarket trading.

$LYTS